Literature DB >> 9708220

Burkholderia cepacia: another twist and a further threat.

A K Webb, J R Govan.   

Abstract

Mesh:

Year:  1998        PMID: 9708220      PMCID: PMC1745229          DOI: 10.1136/thx.53.5.333

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  6 in total

1.  Pseudomonas and all that.

Authors:  C A Hart; C Winstanley
Journal:  Arch Dis Child       Date:  1999-07       Impact factor: 3.791

Review 2.  Infection control in cystic fibrosis: methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and the Burkholderia cepacia complex.

Authors:  J R Govan
Journal:  J R Soc Med       Date:  2000       Impact factor: 5.344

3.  Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs.

Authors:  J S Elborn; R J Prescott; B H Stack; M C Goodchild; J Bates; C Pantin; N Ali; D J Shale; M Crane
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

4.  Discrimination of Burkholderia multivorans and Burkholderia vietnamiensis from Burkholderia cepacia genomovars I, III, and IV by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Suppurative mediastinitis secondary to Burkholderia cepacia in a patient with cystic fibrosis.

Authors:  Ronald B George; Yannick Cartier; Alan G Casson; Paul Hernandez
Journal:  Can Respir J       Date:  2006 May-Jun       Impact factor: 2.409

6.  The practical application and interpretation of simple lung function tests in cystic fibrosis.

Authors:  P L Brand; C K van der Ent
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.